TABLE 1.
Characteristics of study participants (ITT population)
| Characteristic | Two-dose group (ages 5 to 8 yr)
|
One-dose group (ages 9 to 49 yr)
|
||
|---|---|---|---|---|
| CAIV-T (n = 186) | LAIV (n = 190) | CAIV-T (n = 285) | LAIV (n = 281) | |
| Age (yr) | ||||
| Mean (SDa) | 6.4 (1.11) | 6.6 (1.11) | 26.3 (11.37) | 25.8 (11.62) |
| Median | 6 | 7 | 25 | 25 |
| Percentile (25th-75th) | 5-7 | 6-8 | 16-35 | 15-35 |
| Range | 5-8 | 4-8b | 9-49 | 9-49 |
| Sex (no. [%] male) | 100 (53.8) | 104 (54.7) | 122 (42.8) | 125 (44.5) |
| Race/ethnicity (no. [%] of subjects) | ||||
| White/non-Hispanic | 128 (68.8) | 126 (66.3) | 238 (83.5) | 232 (82.6) |
| Black | 24 (12.9) | 29 (15.3) | 24 (8.4) | 24 (8.5) |
| Hispanic | 30 (16.1) | 28 (14.7) | 17 (6.0) | 23 (8.2) |
| Asian | 0 (0.0) | 1 (0.5) | 2 (0.7) | 1 (0.4) |
| Other | 4 (2.2) | 6 (3.2) | 4 (1.4) | 1 (0.4) |
a
SD, standard deviation.
b
One subject in the two-dose group (ages 5 to 8 years) who received LAIV was 59 months old at the time of the dose 1 vaccination.